LOTTE Biologics announces four-party MOU to build three biologics plants

Jun 20, 2023

LOTTE Biologics announced it has signed a memorandum of understanding with LOTTE Corporation, Incheon Metropolitan City and the Incheon Free Economic Zone to establish biologics production facilities in the area.  LOTTE Biologics plans to construct three mega plants by 2030, that can produce 360,000L of biologic therapeutics.

On 8 June 2023, Samsung Biologics and Pfizer announced a US$411M collaboration to manufacture biosimilars in Korea.

Print Page Mail Article